We have previously shown that Vγ9Vδ2 T cells achieve efficacy against NPC when BTN2A1 and BTN3A1 are upregulated by stimulating EBV gene expression, particularly LMP1. This evidence concerns the gene BTN2A1 and nasopharyngeal carcinoma.